Wess Stafford
Helping today to
Fight SMA together
Bethesda Children's Hospital and EliMo Foundation are working together to help children with SMA and provide them the Zolgensma therapy.
SMA is a rare neuromuscular disorder that results in the loss of motor neurons and progressive muscle wasting.
We who are strong ought to bear with the failings of the weak...
ROMANS 15:1
We can help with
ZOLGENSMA Genetherapy
ZOLGENSMA® (onasemnogene abeparvovec-xioi) is a genetherapy used in the treatment of children diagnosed with muscular dystrophy (spinal muscular atrophy (SMA), which was granted valid marketing authorisation as a registered drug treatment across the entire territory of the European Union on 18 May 2020.
When can
We Help
Read in detail about the primary conditions for admission to the programme and all the additional medical criteria.
Check out our
SUCCESS STORIES
How can you
Apply for the ZOLGENSMA genetherapy
Please make sure you read carefully the detailed information about the main points of the authorization procedure.
